# Ivermectin Versus Standard Treatment in Mild COVID-19

> **NCT04937569** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 1644 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin Tablets

## Key facts

- **NCT ID:** NCT04937569
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 1644 (ESTIMATED)
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937569, "Ivermectin Versus Standard Treatment in Mild COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*